Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2011; 136(17): 896
DOI: 10.1055/s-0031-1275824
DOI: 10.1055/s-0031-1275824
Pro & contra | Commentary
Onkologie, Chirurgie
© Georg Thieme Verlag KG Stuttgart · New York
Metastasenchirurgie bei neuroendokrinen Tumoren – pro
Resection of metastases in neuroendocrine tumors: proFurther Information
Publication History
Publication Date:
26 April 2011 (online)
Schlüsselwörter
neuroendokrine Tumoren - Lebermetastasen - Lungenmetastasen - kurative Resektion - palliative Situation - ablative Verfahren
Keywords
neuroendocrine tumors - liver metastases - lung metastases - curative resection - palliation - ablative strategies
Literatur
- 1 Arnold R. et al . Placebo-controlled, double-blind, prospective, randomized study of the effect of octreotide LAR in the control of tumor growth in pat. with metastatic neuroendocrine midgut tumors. J Clin Oncol. 2009; 27 4656-4663
- 2 Fürst G. et al . Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration. Radiology. 2007; 243 171-179
- 3 Plöckinger U. et al . Guidelines for the Diagnosis and Treatment of neuroendocrine Gastrointestinal Tumors. Neuroendocrinology. 2004; 80 394-424
- 4 Steinmüller T. et al . Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors. Neuroendocrinology. 2008; 87 47-62
- 5 Touzios J. et al . Neuroendocrine hepatic metastases: does aggressive management improce survival?. Ann Surg. 2005; 241 776-783
Prof. Dr. W. T. Knoefel
Klinik für Allgemein-, Viszeral-
und Kinderchirurgie
Universitätsklinikum Düsseldorf
Moorenstr. 5
40005 Düsseldorf
Email: knoefel@med.uni-duesseldorf.de